» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Name & Property Search

Name & Property Search

Search results for 'Robert Califf' | Search again
DeSoto Public Records:0
Shelby Public Records:0
Editorial:15
West Tennessee:0
Middle Tennessee:0
East Tennessee:0
Other:0

You must be a subscriber to see the full results of your search.

Please log in or subscribe below if you are not already a subscriber.

TNLedger Knoxville Edition subscribers get full access to more than 13 million names and addresses along with powerful search and download features. Get the business leads you need with powerful searches of public records and notices. Download listings into your spreadsheet or database.

Learn more about our services | Search again


Editorial Results (free)

1. FDA head: Baby formula factory could reopen by next week -

WASHINGTON (AP) — The head of the Food and Drug Administration told lawmakers Thursday that a shuttered baby formula factory could be up and running as soon as next week, though he sidestepped questions about whether his agency should have intervened earlier to address problems at the plant that have triggered the national shortage.

2. Lawmakers grill FDA commissioner over baby formula shortage -

WASHINGTON (AP) — The head of the Food and Drug Administration faced congressional lawmakers for the first time Thursday over the shortage of baby formula that has rattled American parents and become a growing political liability for President Joe Biden.

3. House Dems propose $28 million to address formula shortage -

WASHINGTON (AP) — House Democrats unveiled a $28 million emergency spending bill Tuesday to address the shortage of infant formula in the United States.

Rep. Rosa DeLauro, the Democratic chair of the House Appropriations Committee, said the bill would help the Food and Drug Administration take important steps to restore the formula supply in a safe and secure manner.

4. White House says deal near to reopen formula plant -

WASHINGTON (AP) — Under fire from parents and politicians, President Joe Biden's administration on Monday is expected to announce an agreement to reopen the largest domestic manufacturing plant of infant formula and to ease import rules to allow supplies in from overseas, amid a nationwide shortage spurred by the Michigan plant's shutdown earlier this year over safety issues.

5. FDA to issue plan banning menthol in cigarettes, cigars -

WASHINGTON (AP) — The U.S. government on Thursday released its long-awaited plan to ban menthol cigarettes and flavored cigars, citing the toll on Black smokers and young people.

"The proposed rules would help prevent children from becoming the next generation of smokers and help adult smokers quit," said Health and Human Services Secretary Xavier Becerra, in a statement.

6. E-cigs using synthetic nicotine come under FDA oversight -

WASHINGTON (AP) — U.S. regulators will soon begin cracking down on vaping companies using a now-closed loophole, including a line of fruit-flavored e-cigarettes that have become teenagers' top choice.

7. Biden agency vacancies to drag on White House priorities -

WASHINGTON (AP) — For more than a year, the Food and Drug Administration lacked a permanent head when the agency was central in the battle against COVID-19. Once President Joe Biden nominated Dr. Robert Califf to head the agency, it took the Senate three months to confirm him.

8. Senate confirms Biden's FDA pick despite political divisions -

WASHINGTON (AP) — The Senate narrowly confirmed President Joe Biden's pick to lead the Food and Drug Administration on Tuesday pushing past a thicket of political controversies that threatened to derail what was initially expected to be an easy confirmation.

9. FDA's agenda in limbo as Biden's nominee stalls in Senate -

WASHINGTON (AP) — President Joe Biden's pick to lead the Food and Drug Administration has stalled in the narrowly divided Senate, an unexpected setback that could delay decisions on electronic cigarettes and a raft of other high-profile health issues pending at the agency.

10. Biden picks former FDA chief Califf to again lead the agency -

WASHINGTON (AP) — President Joe Biden on Friday is tapping former Food and Drug Administration commissioner Robert Califf to again lead the powerful regulatory agency, according to a person familiar with the decision.

11. FDA will require e-cigarettes and contents to be reviewed -

WASHINGTON (AP) — The federal government announced sweeping new rules Thursday for electronic cigarettes that will for the first time require the devices and their ingredients to be reviewed, a mandate that could offer protection for consumers and upend a multibillion dollar industry that has gone largely unregulated.

12. FDA outlines standards for anti-abuse generic painkillers -

WASHINGTON (AP) — Federal officials are encouraging generic drugmakers to reformulate their painkillers to make them harder to abuse, the latest in a string of steps designed to combat abuse of highly-addictive pain drugs like codeine and oxycodone.

13. Senate panel approves Dr. Robert Califf as FDA commissioner -

WASHINGTON (AP) — A Senate panel has voted to approve Dr. Robert Califf to be commissioner of the Food and Drug Administration, but the nomination may face trouble on the Senate floor.

14. Outgoing FDA chief saw changes to food safety, tobacco rules -

WASHINGTON (AP) — From food safety to tobacco regulation and politically charged drug approvals, Margaret Hamburg reset the course of the embattled Food and Drug Administration.

After nearly six years as FDA commissioner, Hamburg announced her resignation Thursday in an email to staff. She said the agency's chief scientist, Stephen Ostroff, will serve as acting head of FDA.

15. Outgoing FDA chief saw changes to food safety, tobacco rules -

WASHINGTON (AP) — From food safety to tobacco regulation and politically charged drug approvals, Margaret Hamburg reset the course of the embattled Food and Drug Administration.

After nearly six years as FDA commissioner, Hamburg announced her resignation Thursday in an email to staff. She said the agency's chief scientist, Stephen Ostroff, will serve as acting head of FDA.